New Drug For Cancers Caused By Viruses, LSU Health Sciences Center Study

Published: Jan 15, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Christopher Parsons, MD, Director of the HIV Malignancies Program at LSU Health Sciences Center New Orleans, is the senior author of a paper that is the first to report that specialized fat (lipid) molecules, called sphingolipids, play a key role in the survival of aggressive lymphomas caused by viruses. The paper also reveals a new therapy for preventing production of sphingolipids by lymphoma cells, thereby killing these cells, which are often resistant to standard therapies. The study is published in the January 2014 issue of Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news